Correlation Between Alector and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Alector and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alector and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alector and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Alector and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alector with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alector and Biomarin Pharmaceutical.
Diversification Opportunities for Alector and Biomarin Pharmaceutical
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Alector and Biomarin is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Alector and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Alector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alector are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Alector i.e., Alector and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Alector and Biomarin Pharmaceutical
Given the investment horizon of 90 days Alector is expected to generate 2.46 times more return on investment than Biomarin Pharmaceutical. However, Alector is 2.46 times more volatile than Biomarin Pharmaceutical. It trades about -0.02 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.05 per unit of risk. If you would invest 960.00 in Alector on August 27, 2024 and sell it today you would lose (566.00) from holding Alector or give up 58.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alector vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Alector |
| Biomarin Pharmaceutical |
Alector and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alector and Biomarin Pharmaceutical
The main advantage of trading using opposite Alector and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alector position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Alector vs. Eliem Therapeutics | Alector vs. HCW Biologics | Alector vs. Scpharmaceuticals | Alector vs. Milestone Pharmaceuticals |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets |